E89R
TEAS SECTION 8 & 9 RECEIVED
08/14/2026
Back to search
Official data from USPTO
RX DAYTONA PLUS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
RX DAYTONA PLUS
ST13
US500000085762758Class
1, 5, 9, 10
Filing
85762758
Registration
5019977
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
47
Latest update
08/14/2026
Trademark type
Word
Nice classes
1, 5, 9, 10
Filing date
10/24/2012
Registration date
08/16/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/03/2023
Last transaction
08/14/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
99
Owner location
Crumlin, Antrim, GB
Examiner
LOBO, DEBORAH E
Law office
L90
Current location
TMEG LAW OFFICE 109
Holders and representatives
Holders
Randox Laboratories Ltd
Representatives
Douglas N. Masters LOEB & LOEB LLP
Technical classification
Nice Classes
Class 1Class 5Class 9Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals used in industry and science; chemical preparations for use in photography; chemicals for use in agriculturehorticulture and forestry except fungicidesherbicidesinsecticides and parasiticides; chemical reagents for non-medical purposes; enzymes and proteins for scientific and medical research; diagnostic preparations for scientific purposes; diagnostic kits consisting primarily of diagnostic preparations for analysis of food products and water for scientific or research purposes; diagnostic preparations and reagents for clinical use; diagnostic scanning reagents for scientific use; diagnostic preparations for medical laboratory testing
Class 5
Blood serum and antiserum for use as medical diagnostic reagents; diagnostic preparations for medical and veterinary use; kits consisting primarily of diagnostic preparations for medical use; diagnostic scanning agents for medical purposes; clinical diagnostics preparations for medical and veterinary use; diagnostic testing preparations for medical and veterinary use; reagents for use in diagnostic tests for medical and veterinary purposes; reagents for use with analyzers for medical and veterinary purposes
Class 9
Computer software for schedulingprogramminganalysing and reporting on diagnostic tests in the field of biomarkers; computer software for automatic calibrationbarcode scanningreagent information managementreaction process monitoring and cross-contamination prevention in the field of biomarkers; computer software for patient information memory and association inputreport auditingprinting and publishing diagnostic test results and statistics in the field of biomarkers; laboratory devices for detecting chemical compounds and reagents in the field of biomarkers for research use; diagnostic apparatus and instruments for the testing of clinical chemistrytoxicologyfood and winenot for medical purposes; diagnostic testing apparatus and instruments for use in immunoassay proceduresnot for medical purposes; diagnostic imaging apparatus for the study of chemical compounds and structures other than for medical use; clinical laboratory analytical instruments other than for medical useclinical chemistry or immunoassay analysers
Class 10
Medical apparatus and instruments for use in biomarker diagnostics; diagnostic apparatus and instruments for medical usebiomarkers for detecting and analysing infectious and non-infectious diseasesorgan function in humans and animalstherapeutic drugs and drugs of abuseproteinsacids and antioxidants; electromagnetic diagnostic imaging apparatus for medical use; clinical chemistry analyzers for diseasetoxicology and bodily function analysis for medical and veterinary use in the field of biomarker diagnostics; medical diagnostic testing apparatus and instruments for use in immunoassay procedures
Publications
History of USPTO decisions and trademark events.
47 publications found
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/16/2025
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
03/03/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
03/03/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/03/2023
E815
TEAS SECTION 8 & 15 RECEIVED
08/16/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/16/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
08/16/2016
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
07/12/2016
IUCN
NOTICE OF ALLOWANCE CANCELLED
07/11/2016
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
07/11/2016
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/27/2016
EX3G
SOU EXTENSION 3 GRANTED
01/26/2016
EXT3
SOU EXTENSION 3 FILED
12/29/2015
EEXT
SOU TEAS EXTENSION RECEIVED
12/29/2015
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/16/2015
EX2G
SOU EXTENSION 2 GRANTED
07/15/2015
EXT2
SOU EXTENSION 2 FILED
07/03/2015
EEXT
SOU TEAS EXTENSION RECEIVED
07/03/2015
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/20/2015
EX1G
SOU EXTENSION 1 GRANTED
02/19/2015
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/17/2015
EXT1
SOU EXTENSION 1 FILED
01/06/2015
EEXT
SOU TEAS EXTENSION RECEIVED
01/06/2015
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/06/2015
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/15/2014
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/20/2014
PUBO
PUBLISHED FOR OPPOSITION
05/20/2014
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/30/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/16/2014
ALIE
ASSIGNED TO LIE
04/15/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/21/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/21/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/20/2014
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
03/20/2014
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
09/25/2013
GNFR
FINAL REFUSAL E-MAILED
09/25/2013
CNFR
FINAL REFUSAL WRITTEN
09/25/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/22/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/22/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/22/2013
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/22/2013
GNRT
NON-FINAL ACTION E-MAILED
02/22/2013
CNRT
NON-FINAL ACTION WRITTEN
02/22/2013
DOCK
ASSIGNED TO EXAMINER
02/21/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/30/2012
NWAP
NEW APPLICATION ENTERED
10/27/2012
Continuous trademark protection
Get notified about every new filing that threatens RX DAYTONA PLUS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.